Status: Recruiting
Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL
To evaluate the safety and efficacy of autologous hematopoietic stem cell transfer (ASCT) combined with CD7-CART in the treatment of CD7+ TCL
Participants needed: 50
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Aug 6, 2025Locations: 1
Eligibility criteria
With the subject's consent and having signed the informed consent form, willing... [+5]
History of allergy to any of the components in the cell product; [+7]